Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Issues Public Stock Offering Valued at $61.9 Million

NEW YORK, Feb. 12 (GenomeWeb News) - Cepheid is offering 5.5 million shares of common stock at a public offering price of $11.25 per share, the company said today.


The total value of the offering is $61.9 million.


Cepheid also said it has granted its underwriters an option to purchase up to an additional 825,000 shares of common stock to cover over-allotments. UBS Securities is the sole book-running manager for the offering. William Blair & Company, C.E. Unterberg, Towbin, and Rodman & Renshaw are acting as co-managers.



The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.